Health Economics and Policy

The five-year follow-up data are in. Half of all patients retain BCVA of 20/40 or better, irrespective of drug used

Boosting banana carotenoid levels could reduce vision loss – particularly in Africa and Southeast Asia

Many patients visit the emergency room with ocular problems that might be better treated elsewhere – why? And what’s the solution?

Could patient self-testing help to free up eye clinics, and spot macular degeneration earlier than traditional testing methods?

OpenPrescribing.net shows some interesting trends in ophthalmic therapy prescription and spend over the last five years

A future of skyrocketing patient numbers in the clinic and technological advances means that the routine eye exam of tomorrow has to be substantially different. But how?

You might want to do the right thing and get stuck in – but there’s a bigger picture to be seen before you do.

“In Conversation With...”, an ongoing series of informal interviews with some of the biggest personalities in ophthalmology in glorious settings around the globe.

The Greek bailouts came with a price: austerity. This might come to pass as a highly myopic move. We explore its impact on ophthalmology – and the future health economic toll it will take on Greek society.

The rise of the experience economy means that ophthalmology practices must go to great lengths to ensure their patients are receiving not just the best medical care, but also the best possible customer service